
PEMF vs Red Light Therapy: Which Is Better for Pain?
Should I buy a PEMF mat or a red light panel?
Red light therapy scores 8.0 and PEMF 7.5, so the panel is the better first buy for most people. PEMF wins on bone and joint pain, where a magnetic field reaches tissue photons cannot. Red light wins mitochondrial signaling, wound healing, recovery, mood and circadian support. Buy for the complaint you actually have.
- Red light therapy 8.0 with high evidence confidence, PEMF 7.5 with moderate. The panel is the lower-regret first device.
- A field is not a photon. PEMF induces small tissue currents that shift calcium signaling and damp NF-kB. Red light is absorbed by cytochrome c oxidase in mitochondria. They are complementary, not duplicates.
- Depth is the whole argument. A magnetic field passes through bone and body mass. Red at 630-660 nm reaches skin, near-infrared at 810-850 nm reaches a few centimeters, and neither reaches a hip.
- PEMF wins one row outright: bone-joint 8.0 against 7.2. That is also where its regulated use lives, in prescription bone-growth stimulators.
- Red light dosing is measurable in mW/cm2 and J/cm2. PEMF dosing is not standardized across devices, and output claims often go unverified.
- Both are one-time hardware, not subscriptions. Red light runs an ESTIMATE $17 to $43 a month amortised, PEMF an ESTIMATE $3 to $117 depending entirely on which device you buy.
- Implants decide it for some people. Pacemakers, defibrillators, cochlear implants and insulin pumps rule out PEMF outright.
At a Glance
PEMF (Pulsed Electromagnetic Field Therapy)
- Efficacy 3.6
- Breadth 3.6
- Evidence 3.7
- Speed 3.0
- Durability 2.6
- Bioindividuality 3.3
- Safety Risk 1.4
- Side Effects 1.2
- Cost 3.2
- Effort 2.2
- Opportunity Cost 2.0
- Dependency 1.0
- Reversibility 1.0
- Bone Joint
- Injury Recovery
- Acute Pain
- Chronic Pain
Pulsed magnetic field, 1-100 Hz and 1-10 mT in consumer devices. BioHarmony 7.5, strong recommend, moderate confidence.
Red Light Therapy
- Efficacy 3.8
- Breadth 4.8
- Evidence 4.0
- Speed 3.5
- Durability 2.8
- Bioindividuality 3.5
- Safety Risk 1.4
- Side Effects 1.3
- Cost 3.0
- Effort 2.5
- Opportunity Cost 1.0
- Dependency 1.2
- Reversibility 1.0
- Mitochondrial
- Wound Healing
- Skin Beauty
- Hair Nail
Photobiomodulation at 630-700 nm and 810-850 nm. BioHarmony 8.0, strong recommend, high confidence.
Head-to-Head Verdict
| Use Case | Winner | Rationale |
|---|---|---|
| Bone Joint | PEMF (Pulsed Electromagnetic Field Therapy) | PEMF 8.0 against red light therapy 7.2, the only row where PEMF leads on score. Tong 2022 pooled 11 osteoarthritis RCTs in 614 patients with favorable pain, stiffness and function effects, and Bagnato 2016 found short-term knee OA improvement in 60 completers. The FDA's bone-growth stimulator record covers PEMF devices for nonunion and fusion. Light has no comparable bone indication. |
| Chronic Pain | PEMF (Pulsed Electromagnetic Field Therapy) | The subratings are level at 7.0 each, so depth breaks the tie. Kull 2025 pooled 9 RCTs in 420 people with non-specific low back pain and found a favorable direction, and Wu 2018 found knee and hand OA benefit across 12 trials. Red light's best pain evidence, Fan 2024, is a knee-surface target at low certainty. If the painful structure is deep, a field reaches it and a photon does not. |
| Mitochondrial | Red Light Therapy | Red light therapy 8.5 against PEMF 6.0, the widest gap in the matrix. Karu 2010 identifies cytochrome c oxidase as the photoacceptor, so mitochondrial signaling is the mechanism itself rather than a downstream consequence. PEMF's calcium signaling can touch ATP production, but Su 2024 is a mechanism review and direct human mitochondrial outcome evidence stays thin. |
| Wound Healing | Red Light Therapy | Red light therapy 8.3 against PEMF 6.5. Hamblin 2017 details the angiogenesis, collagen and inflammatory pathways behind photobiomodulation, with Avci 2013 on the dermatology side. PEMF's wound case is real but surgical: Stocchero 2015 found fewer healing complications after third molar extraction, Rohde 2015 less exudate after breast reconstruction. Pradal 2025 caps both, null for burns. |
| Recovery Repair | Red Light Therapy | Red light therapy 7.8 against PEMF 7.0. Leal-Junior 2015 pooled 13 RCTs in roughly 650 people and found positive muscle performance effects with a DOMS effect size of 0.45. PEMF's recovery evidence splits: Stocchero 2015 supports soft-tissue healing while Perumal 2022 randomized 118 people and found no superiority over placebo for post-appendectomy pain. |
| Circadian Rhythm | Red Light Therapy | Red light therapy 7.5 against PEMF 5.8. Neither is a true zeitgeber and neither report claims one, but red and near-infrared exposure earlier in the day adds light load without the melatonin suppression profile of blue-rich evening light. A pre-bed PEMF mat session is relaxation timing, not phase shifting, and no human RCT shows PEMF entrains melatonin or core temperature rhythm. |
| Mood | Red Light Therapy | Red light therapy 7.0 against PEMF 5.8, and the citation quality is the reason. Ji 2024 pooled 11 trials in 407 people and found a depression effect size of -0.55, with sleep nonsignificant. The PEMF mood case rests on Martiny 2010 in treatment-resistant depression, which the audit could not fully verify, and it is a transcranial protocol rather than anything a consumer mat delivers. |
| Acute Pain | Tie | Call this even. Red light therapy 7.5 against PEMF 7.2 is inside the noise and both sides carry a real trial. Hackel 2025 enrolled 120 people, with complete data on 91, and found greater 14-day joint and soft-tissue pain reduction with PEMF than standard care. Fan 2024 pooled 13 RCTs in 673 people for a knee OA pain effect size of 0.96, at low certainty. |
| Injury Recovery | Tie | Red light therapy 7.8 against PEMF 7.5, too close to split, and the two cover different tissue. Lawrence 2024 finds low-level laser therapy promising for surface wounds and localized sport recovery, weaker for deep acute injury. Picelli 2024 pooled 3 RCTs in 197 people and did not support acute fracture healing, while Shi 2013 supports delayed union under prescription. |
Cost Comparison
| Intervention | Monthly Cost | Notes |
|---|---|---|
| PEMF Therapy | $3 to $117 | ESTIMATE, priced 2026-09-08, one-time hardware. This is not a monthly bill. The report prices entry-level mats around $200 and premium full-body systems at $4,000 to $7,000, and the monthly figure is that purchase amortised over a five-year life. There are no consumables beyond electricity.The 39-fold spread is the point: it reflects which device you buy, not how often you use it. Targeted handhelds sit near $600. Prescription bone-growth stimulators are a separate clinical market with their own pricing and their own indications. Dose at that price is a 20 to 30 minute mat session. |
| Red Light Therapy | $17 to $43 | ESTIMATE, priced 2026-09-07, one-time hardware. The report puts a serious home panel at $1,000 to $2,500. Amortised over five years that is $17 to $42 a month, plus roughly $1 of electricity.Clinic sessions at $30 to $60 each are the alternative if you would rather not own hardware, which makes this the easier of the two to test before buying. Dose at that price is 10 to 20 minutes at 6 to 12 inches, rotating chest, face and back. |
| The difference | Overlapping ranges, so the device decides, not the category | Both numbers are amortised hardware estimates from the source reports, not measured retail and not per-session prices. Neither report priced a specific brand. A cheap PEMF mat undercuts every red light panel and a premium PEMF system costs several times the most expensive panel, so the category comparison tells you almost nothing on its own.What the money actually buys is different in kind. On the panel you are paying for verified irradiance at a real treatment distance. On PEMF you are paying for a documented frequency, field strength and waveform. If a seller on either side cannot produce those numbers, the price is not the problem with that device. |
When to Switch
These two run on different clocks, so do not judge them on the same date. PEMF gives a first noticeable effect within about a day, assesses at 8 weeks and reaches full effect at 8 weeks, so two months of daily sessions is a complete trial. Red light takes about 2 weeks for a first change, assesses at 12 weeks and peaks at 24. Judging a panel at 4 weeks is how buyers quit a device that was working.
Move from the panel to PEMF when the target is deep and structural: an arthritic knee or hip, a healing bone under orthopedic supervision, low back pain that already failed the basics. Move from PEMF to the panel when the target is reachable or mitochondrial: skin, scalp, a superficial tendon, post-training soreness, mood, daytime light load.
Move to the panel immediately, without a trial, if you have a pacemaker, an implanted defibrillator, a cochlear implant or an insulin pump. Those close the PEMF door entirely.
Overlapping them is reasonable rather than wasteful. A pulsed magnetic field and an absorbed photon share only a nitric oxide node, so most of the biology is separate. If you run both, keep the panel near training and the mat pre-bed, and start one at a time. Starting both at once, on an 8-week and a 12-week clock, guarantees you will not know which one did it.
Who Should Pick What?
First device, general interest, no specific complaint
Red Light Therapy
Higher overall score (8.0 against 7.5), higher evidence confidence, a breadth subscore of 4.8 out of 5.0 against 3.6, and a lower opportunity cost score. It is the lower-regret purchase when you do not yet know what you are treating, and clinic sessions let you test the response first.
Knee or hand osteoarthritis after strength work and weight management
PEMF (Pulsed Electromagnetic Field Therapy)
Bone-joint 8.0 against 7.2. Tong 2022 pooled 11 OA RCTs in 614 patients and Wu 2018 found knee and hand benefit across 12 trials, while Li 2013 concluded electromagnetic fields probably relieve OA pain with uncertain function effects. Use parameters close to validated clinical devices and run a minimum 4-week block.
Healing a nonunion fracture or a spinal fusion
PEMF (Pulsed Electromagnetic Field Therapy)
This is the one context where the device is regulated rather than recreational. The FDA's bone-growth stimulator record lists non-invasive pulsed electromagnetic-field devices for specific indications, and those protocols run 3 or more hours a day for months. Get it prescribed. A consumer mat is not the same thing, and Picelli 2024 found no support for acute fracture healing.
Visible skin aging or early androgenetic alopecia
Red Light Therapy
PEMF does not compete here at all. Lanzafame 2013 recorded a 35% hair-count increase against 2% for sham over 16 weeks, and Wunsch 2014 found wrinkle reduction and collagen-density improvement across 113 people at 30 sessions. No PEMF trial addresses either endpoint.
Anyone with a pacemaker, defibrillator, cochlear implant or insulin pump
Red Light Therapy
The decision is made for you. Active electronic implants are an absolute PEMF contraindication because electromagnetic interference can disrupt device function. Red light carries no equivalent restriction, though eye protection at high irradiance still applies.
Athlete managing post-training soreness
Red Light Therapy
Recovery-repair 7.8 against 7.0 and strength-power 6.2 against 5.0. Leal-Junior 2015 pooled 13 RCTs for muscle performance and a DOMS effect size of 0.45. Dose the worked muscle at 6 inches for 10 to 15 minutes and judge by soreness, bar speed and next-day repeatability, not by feel during the session.
Low mood alongside a physical complaint
Red Light Therapy
Mood 7.0 against 5.8. Ji 2024 pooled 11 trials in 407 people for a depression effect size of -0.55. PEMF's depression signal comes from transcranial protocols in treatment-resistant patients, not from a mat, and the audit could not fully verify that citation. Neither replaces treatment when depression is significant.
Pregnant, or with an active malignancy in the treatment field
Tie
Neither, without clearance. Pregnancy appears on the PEMF contraindication list outright and limits red light for direct uterine exposure. Active malignancy over or in the treatment area rules out both. Epilepsy adds a cranial-use restriction on PEMF, and photosensitizing medication adds one on red light.
Research Highlights
-
Mechanism Difference
PEMF and red light therapy are complementary, not redundant, and the difference is a field against a photon. PEMF induces small currents in tissue that shift calcium signaling and nitric oxide production, stimulate osteoblasts and damp NF-kB-driven inflammatory signaling. Its targets are voltage-gated calcium channels, endothelial nitric oxide synthase and NF-kB.Red light therapy works by absorption. Photons at 630 to 700 nm and 810 to 850 nm are taken up by cytochrome c oxidase, which Karu 2010 identified as the photoacceptor, releasing nitric oxide from complex IV and upregulating ATP. Nitric oxide is the single node the two share. Everything else is separate biology, which is why owning both is not duplication.
-
Safety Comparison
Both are low-risk and both score 1.4 out of 5.0 on safety risk. PEMF is marginally better on side effects, 1.2 against 1.3. That is not the useful difference. The useful difference is one absolute exclusion PEMF carries and red light does not: pacemakers, defibrillators, cochlear implants and insulin pumps, because electromagnetic interference can disrupt them.PEMF also restricts pregnancy, active malignancy over the treatment area and cranial use with epilepsy. Red light restricts active melanoma or a suspected malignant pigmented lesion in the field, photosensitizing medication such as isotretinoin or tetracyclines, direct uterine exposure in pregnancy, and use without eye protection at high irradiance.
-
Cost Comparison
Neither of these is a monthly bill. Both are one-time hardware purchases that the reports amortise over a five-year life. A serious red light panel at $1,000 to $2,500 works out to $17 to $43 a month including about $1 of electricity, priced 2026-09-07. PEMF spans $3 to $117 a month on the same basis, from a $200 entry mat to a $4,000 to $7,000 full-body system, priced 2026-09-08.Both figures are ESTIMATE ranges from the source reports, not measured retail. The PEMF spread is about which device you buy rather than how much you use it, so the category comparison decides nothing. Red light has one practical advantage on money: clinic sessions at $30 to $60 let you test the response before you own anything.
-
Onset
The two devices reward patience differently, and that matters more than most buyers expect. PEMF gives a first noticeable effect within about a day, assesses at 8 weeks and reaches full effect at 8 weeks. Two months of daily 20 to 30 minute sessions is a complete trial with nothing left to wait for.Red light therapy takes about 2 weeks before anything is noticeable, assesses at 12 weeks and does not reach full effect until 24 weeks. The report's own onset notes put visible skin softening at 4 to 8 weeks, collagen-density change past 12 weeks and hair-count change at 16 to 24 weeks. Judging a panel on a PEMF timeline is how people abandon a working device.
-
Editorial Verdict
Buy the panel first. Red light therapy scores 8.0 with high evidence confidence against PEMF's 7.5 with moderate, wins 16 of the 18 shared use cases on subrating, and carries a breadth subscore of 4.8 out of 5.0 against 3.6. Its dosing is also measurable in mW/cm2 and J/cm2, where PEMF output claims vary dramatically between brands.Buy PEMF when the target is deep and structural. It leads bone-joint 8.0 against 7.2, ties chronic pain at 7.0 with better pooled evidence behind it, and owns the one regulated indication in this comparison through prescription bone-growth stimulators. If you have an active electronic implant, the choice is already made: PEMF is out, and no benefit outweighs that.
Frequently Asked Questions
- Which should I buy first, a PEMF mat or a red light panel?
- The panel, for most people. Red light therapy scores 8.0 with high evidence confidence against PEMF's 7.5 with moderate, and it leads 16 of the 18 shared use cases on subrating. Buy PEMF first only if your problem is deep and structural: an arthritic knee or hip, a healing bone under an orthopedist, or non-specific low back pain that has already failed the basics.
- Do PEMF and red light do the same thing?
- No. PEMF induces small electrical currents in tissue that shift calcium signaling and nitric oxide production, stimulate osteoblasts and damp NF-kB inflammatory signaling. Red light is absorbed by cytochrome c oxidase in mitochondria, releasing nitric oxide from complex IV and upregulating ATP. They share only that nitric oxide node, so running both is not duplication.
- Which one goes deeper into the body?
- PEMF, and it is not close. A pulsed magnetic field passes through soft tissue and bone without being absorbed on the way in, which is why prescription bone-growth stimulators exist at all. Light is absorbed as it travels: red at 630 to 700 nm treats skin and hair, near-infrared at 810 to 850 nm reaches joints and muscle, and neither wavelength reaches a hip or a spinal fusion.
- Which is better for joint pain?
- It depends on the joint. PEMF leads bone-joint 8.0 against 7.2, with Tong 2022 pooling 11 OA RCTs in 614 patients and Wu 2018 finding knee and hand benefit across 12 trials. Red light's knee evidence, Fan 2024, pooled 13 RCTs in 673 people for a pain effect size of 0.96 but at low to very low certainty. A surface knee can go either way. A deep or covered joint goes to PEMF.
- How much do they actually cost?
- Both are one-time hardware, not subscriptions. Red light runs an ESTIMATE $17 to $43 a month once a $1,000 to $2,500 panel is amortised over five years, plus about $1 of electricity. PEMF runs an ESTIMATE $3 to $117 on the same basis, from a $200 entry mat to a $4,000 to $7,000 full-body system. The PEMF spread is about which device you buy, not how often you use it.
- How long before I know whether it is working?
- Different clocks. PEMF gives a first noticeable effect in about a day, assesses at 8 weeks and reaches full effect at 8 weeks, so two months of daily sessions is a complete trial. Red light takes about 2 weeks for the first signal, 12 weeks to assess and 24 weeks for full effect. Judging a panel at 4 weeks is how people abandon a device that was working.
- Can I use both on the same day?
- Yes, and the mechanisms give you no reason not to. Keep the panel session near training, where Leal-Junior 2015 supports localized recovery, and put the 20 to 30 minute mat session pre-bed as wind-down. Start one at a time for several weeks so you can attribute whatever changes, because an 8-week clock and a 12-week clock running together tell you nothing about which device did it.
- Who should avoid each one?
- PEMF is out entirely with a pacemaker, implanted cardioverter-defibrillator, cochlear implant, insulin pump or other active electronic implant, because electromagnetic interference can disrupt device function. It also restricts pregnancy, active malignancy over the treatment area, and cranial use with epilepsy.Red light restricts active melanoma or a suspected malignant pigmented lesion in the treatment field, active malignancy in the target area without clearance, photosensitizing medication such as isotretinoin, tetracyclines or St John's wort, direct uterine exposure in pregnancy, porphyria and lupus photosensitivity, and use without eye protection at high irradiance.
- Is a consumer PEMF mat the same as a prescription bone-growth stimulator?
- No, and treating it as one is the most expensive mistake in this category. The FDA's bone-growth stimulator record covers specific approved indications such as nonunion fracture and spinal fusion adjuncts, with protocols often running 3 or more hours a day for months. A wellness mat has a different waveform, a different wear time and no such indication. Get the prescription device prescribed.
- Can I trust the dosing numbers on either device?
- More on the panel than on the mat. Red light dosing is measurable in mW/cm2 and J/cm2, with the WALT recommendations behind it, though advertised irradiance is often inflated and only independent testing settles it.Consumer PEMF has no equivalent cross-brand standard and output varies dramatically. A seller who cannot document frequency, field strength and waveform has told you what you need to know.
Evidence Sources
- Meta-analysis The Efficacy of Pulsed Electromagnetic Fields on Pain, Stiffness, and Physical Function in Osteoarthritis: A Systematic Review and Meta-Analysis (2022) 11 RCTs, 614 patients. Favorable pain, stiffness and physical-function signals for PEMF in osteoarthritis.
- RCT Pulsed electromagnetic fields in knee osteoarthritis: a double blind, placebo-controlled, randomized clinical trial (2016) 66 recruited, 60 completed. Short-term pain, function and pressure-threshold improvements.
- Meta-analysis Efficacy and safety of the pulsed electromagnetic field in osteoarthritis: a meta-analysis (2018) 12 trials. Knee and hand OA pain and function benefit, with limited adverse-event reporting.
- Systematic review Electromagnetic fields for treating osteoarthritis, Cochrane Database of Systematic Reviews (2013) 9 studies, 636 participants. Probably relieves OA pain, uncertain physical-function effect, no serious events reported.
- Systematic review Efficacy of pulsed electromagnetic field therapy on pain and physical function in patients with non-specific low back pain: a systematic review (2025) 9 RCTs, 420 participants. Generally favorable pain and function direction with heterogeneous protocols.
- RCT Evaluating Noninvasive Pulsed Electromagnetic Field Therapy for Joint and Soft Tissue Pain Management: A Prospective, Multi-center, Randomized Clinical Trial (2025) 120 enrolled, complete data for 91. 14-day pain reduction favored PEMF over standard care.
- Systematic review Effects of pulsed electromagnetic fields on bone fractures: a systematic review update (2024) 3 RCTs, 197 participants. No significant support for improving acute fracture healing, pain findings contradictory.
- RCT Early application of pulsed electromagnetic field in the treatment of postoperative delayed union of long-bone fractures (2013) Prospective RCT in delayed union after long-bone fracture. Supports the fracture-healing context, not broad wellness use.
- Guideline Bone Growth Stimulators Executive Summary, Orthopaedic and Rehabilitation Devices Panel (2020) FDA summary listing non-invasive bone-growth stimulator approvals, including pulsed electromagnetic-field devices.
- RCT Pulsed Electromagnetic Fields Reduce Postoperative Interleukin-1beta, Pain, and Inflammation (2015) Double-blind placebo-controlled TRAM flap study. Pain, narcotic use, wound exudate and IL-1beta favored PEMF.
- RCT Pulsed electromagnetic fields for postoperative pain: a randomized controlled clinical trial in mandibular third molar extraction (2015) 120 patients. Modest pain and analgesic differences with fewer dehiscence cases.
- RCT Pulsed electromagnetic fields for post-appendicectomy pain management: a randomized, placebo-controlled trial (2022) 118 randomized. PEMF was not superior to placebo for 12-hour post-appendectomy pain or fentanyl use.
- Systematic review Promising application of pulsed electromagnetic fields on tissue repair and regeneration (2024) Mechanism review covering stem cells, inflammation, wound healing and musculoskeletal disorders.
- Preclinical Mitochondrial mechanisms of photobiomodulation in context of new data about multiple roles of ATP (2010) Foundational mechanism work identifying cytochrome c oxidase as the photoacceptor for red and near-infrared light.
- Systematic review Mechanisms and applications of the anti-inflammatory effects of photobiomodulation (2017) Mechanism review covering CCO activation, NF-kB modulation and ROS hormesis.
- Meta-analysis Network meta-analysis on optimal wavelength of LLLT in knee osteoarthritis (2024) 13 RCTs, 673 participants. Pain SMD 0.96 (0.31 to 1.61), 904 to 905 nm ranked highest, certainty low to very low.
- Meta-analysis Effect of phototherapy (LLLT and LEDT) on exercise performance and markers of exercise recovery: meta-analysis (2015) 13 RCTs, around 650 participants. Positive muscle performance effect, DOMS SMD 0.45.
- RCT Effect of low-level laser therapy on androgenetic alopecia: a randomized controlled trial (2013) 44 participants over 16 weeks. 35% hair count increase against 2% for sham.
- RCT A controlled trial of red and near-infrared light treatment for fine lines, wrinkles, skin roughness and intradermal collagen density (2014) 113 participants. Wrinkle reduction and collagen-density improvement at 30 sessions.
- Meta-analysis Photobiomodulation improves depression symptoms: systematic review and meta-analysis (2024) 11 trials, 407 participants. Depression SMD -0.55 (-0.75 to -0.35), sleep outcome nonsignificant.
- Systematic review Photobiomodulation as Medicine: LLLT for Acute Tissue Injury or Sport Performance Recovery (2024) Promising for surface wound healing and localized exercise recovery, less convincing for acute deep-tissue injury.
- Meta-analysis Photobiomodulation in burn wounds: systematic review and meta-analysis (2025) Null finding for burn-wound retraction (SMD -0.22) and collagen deposition (SMD -0.02). Limits enthusiastic wound claims.
- Systematic review Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring (2013) Foundational dermatology review of low-level laser and photobiomodulation applications in skin.
- Guideline WALT dosage recommendations (2010) International low-level laser dosing standards by indication. There is no equivalent cross-brand dosing standard for consumer PEMF.
- Guideline Arthritis of the Knee, AAOS OrthoInfo (2026) Patient guidance states magnetic pulse therapy is painless but has yet to be proven.
Glossary
Quick reference for the medical and technical terms used in this comparison.
- PEMF Pulsed Electromagnetic Field Therapy
- Pulsed magnetic fields, commonly 1 to 100 Hz and 1 to 10 mT in consumer devices, that induce small currents in tissue rather than heating or lighting it.
- PBM Photobiomodulation
- The current scientific term for red and near-infrared light therapy. It describes the panel's mechanism and has no bearing on PEMF.
- LLLT Low-Level Laser Therapy
- The older name for photobiomodulation, still used in most clinical literature including Fan 2024 and Leal-Junior 2015.
- CCO Cytochrome c Oxidase
- Complex IV of the mitochondrial electron transport chain and the primary molecular target of red and near-infrared light, identified by Karu 2010.
- mT Millitesla
- The unit of magnetic field strength. Consumer and clinical PEMF devices commonly run 1 to 10 mT, and a device that will not state this number is not dosable.
- Hz Hertz
- Pulses per second. PEMF protocols commonly run 1 to 100 Hz, with the frequency selected by protocol rather than by preference.
- J/cm2 Joules per square centimeter
- The dose metric for light therapy. Standard target is 10 to 60 J/cm2 per area per session, following a biphasic curve where more is not better.
- mW/cm2 Milliwatts per square centimeter
- Irradiance, or how much light lands on the target. Panels typically deliver 20 to 100 mW/cm2 at 6 to 12 inches, and advertised figures are often inflated.
- NIR Near-Infrared
- Wavelengths roughly 700 to 1,400 nm, used at 810 to 850 nm for deeper tissue. The deepest light in this comparison, and still shallower than a magnetic field.
- NF-kB Nuclear Factor kappa B
- A master inflammatory signaling switch. Both devices modulate it, PEMF through induced currents and calcium signaling, red light through mitochondrial signaling.
- BGS Bone-Growth Stimulator
- An FDA-regulated non-invasive device for specific bone indications such as nonunion and spinal fusion. The one prescription-grade use of pulsed electromagnetic fields.
- SMD Standardized Mean Difference
- A pooled effect size used in meta-analyses. Fan 2024 reported 0.96 for knee OA pain and Ji 2024 reported -0.55 for depression symptoms.